Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC 0409-6102-04
Published March 6, 2013 · Recall initiated: January 10, 2013
Summary
FDA records drug Class II recall D-169-2013, published March 6, 2013 and initiated January 10, 2013. Recalling firm: Hospira, Inc.; Status: Terminated; Reported quantity: 63,900 vials; Lot: 18-099-DK. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial
What to do
Voluntary: Firm initiated · Letter
Get an email if FUROSEMIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FUROSEMIDE
- Manufacturer
- Hospira, Inc.
- Distributor
- Nationwide
- Lot
- 18-099-DK
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFurosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield,April 29, 2026
- FDAFurosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., EastJanuary 28, 2026
- FDAFurosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216,February 1, 2017
- FDAFurosemide Injection, USP, 40 mg/4mL (10 mg/mL), 4 ml Single-Dose Vial, Rx only, HOSPIRA, INC. LAKE FOREST, ILMay 15, 2013
- FDAEXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials,March 6, 2013
- FDABelladonna Alkaloids (hyoscyamine sulfate, USP 0.1037 mg; atropine sulfate, USP 0.0194 mg; scopolamine HBr,March 6, 2013
Questions about this recall
Was Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC 0409-6102-04 recalled?
Yes. FDA published recall D-169-2013 on March 6, 2013. Reported hazard: Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FUROSEMIDE.